
Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs
Author(s): Mark Davison (Author)
- Publisher: Wiley
- Publication Date: 12 Aug. 2011
- Edition: 1st
- Language: English
- Print length: 426 pages
- ISBN-10: 0470616172
- ISBN-13: 9780470616178
Book Description
Editorial Reviews
Review
“The book is an excellent resource and I would recommend it to anyone with either an interest in anti-counterfeiting technology or pharmaceutical counterfeiting in general.” (International Journal of Comparative and Applied Criminal Justice, 26 April 2012)
“Pharmaceutical Anti-Counterfeiting” covers the key concepts and explains the available options in pharmaceutical anti-counterfeiting including a mix of policy, strategy, tactics and practical implementation tips. A must-read for those determined to do something about counterfeit pharmaceutical and healthcare products, and will prove useful to brand protection professionals in other industries.” (Chemanager, 24 January 2012)
“For those determined to take an action against counterfeit pharmaceutical and healthcare products, will find the book useful.” (The Holography Times, 1 December 2011)
“Using accessible and interesting language, Mark Davison talks the reader right the way through the issue of drug counterfeiting – its origins and context within healthcare , the risks presented to companies and consumers alike, anti-counterfeiting strategies and technologies – the result being a definitive guide to the inner workings of the counterfeit industry and a myriad of ways to stymie the counterfeiter’s every step … Reading this book will provide any pharmaceutical brand owner with a solid and informed grounding for making any decisions related to anti-counterfeiting strategy.” (Notofakes.com, 16 November 2011)
“In writing this book Davison has made a great contribution to the global fight against counterfeit drugs. For the first time we have a single reference that collects explanations of every significant anti-counterfeiting technology and approach used around the globe, including both sensory authentication and traceability technologies.” (RxTrace, September 2011)
“Best Pharma Anit-Counterfeiting Book Ever…Davison does not back away from or avoid pointing out conflicts and disagreements that exist between approaches to solving problems (digital vs. physical authentication), but he is quick to help the reader find the strongest solution by seeing the ways that solutions and technologies can work together.” (Randall Burgess, Pharmaceutical AntiCounterfeiting Blog, October 5, 2011)
“Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs by Mark Davison succeeds in providing a handbook for professionals involved in product security and brand protection. . . Davison has a great deal of industry experience in pharmaceuticals as well as product security and is well positioned and qualified to be the one to write this book. The industry owes him a debt of gratitude for committing himself to this effort.” (Pharma AntiCounterfeiting News, 1 August 2011)
“Cambridge-based consultant and entrepreneur Mark Davison, CEO of Blue Sphere Health Ltd, has written a comprehensive guide for drug company executives, technology vendors, healthcare professionals and policy-makers. . . This newly-released 426pp volume is a must-read primer for those determined to do something about counterfeit pharmaceutical and healthcare products, and will prove useful to brand protection professionals in other industries.” (Cambridge Network , 6 September 2011)
From the Inside Flap
Effective strategies to deal with the growing problem of counterfeit drugs
Counterfeit and illegally diverted drugs are a global problem representing a serious threat to patients and to our healthcare systems. To combat fake medicines you need to understand both the problems and the solutions. This book gives you these vital perspectives. It not only provides a detailed examination of the causes and consequences of pharmaceutical counterfeiting, it also provides practical advice and tested and proven strategies to deal with this growing threat to the international drug supply. Moreover, it investigates and explains the tactics and technologies you need to protect your patients, brands, and profits.
Addressing both business and technical issues, this book enables you to understand and tackle the problem of counterfeit and illegally diverted drugs on all fronts:
- Guides you through the complex legal and compliance issues
- Explores the complexities of the drug supply chain, demonstrating why certain approaches to reducing counterfeit drugs are more likely to work than others
- Sets forth the pros and cons of technologies designed to authenticate drugs and secure packaging, to enable traceability or e-pedigree, and to protect the supply chain
- Offers an easy-to-read guide for patients to help them avoid counterfeit drugs
- Illustrates key problems and solutions using realistic examples
- Features anti-counterfeiting case studies from Africa, Asia, Europe, Latin America and North America
Covering pharmaceutical security from factory to patient, this book helps you better understand the issues around counterfeiting and diversion and then implement effective strategies to fight back against these pharmaceutical crimes.
From the Back Cover
Effective strategies to deal with the growing problem of counterfeit drugs
Counterfeit and illegally diverted drugs are a global problem representing a serious threat to patients and to our healthcare systems. To combat fake medicines you need to understand both the problems and the solutions. This book gives you these vital perspectives. It not only provides a detailed examination of the causes and consequences of pharmaceutical counterfeiting, it also provides practical advice and tested and proven strategies to deal with this growing threat to the international drug supply. Moreover, it investigates and explains the tactics and technologies you need to protect your patients, brands, and profits.
Addressing both business and technical issues, this book enables you to understand and tackle the problem of counterfeit and illegally diverted drugs on all fronts:
- Guides you through the complex legal and compliance issues
- Explores the complexities of the drug supply chain, demonstrating why certain approaches to reducing counterfeit drugs are more likely to work than others
- Sets forth the pros and cons of technologies designed to authenticate drugs and secure packaging, to enable traceability or e-pedigree, and to protect the supply chain
- Offers an easy-to-read guide for patients to help them avoid counterfeit drugs
- Illustrates key problems and solutions using realistic examples
- Features anti-counterfeiting case studies from Africa, Asia, Europe, Latin America and North America
Covering pharmaceutical security from factory to patient, this book helps you better understand the issues around counterfeiting and diversion and then implement effective strategies to fight back against these pharmaceutical crimes.
About the Author
MARK DAVISON, CEO of Blue Sphere Health, is a pharmaceutical consultant and entrepreneur with more than twenty years of industry experience. He was formerly business development director for healthcare at SICPA, one of the world’s leading anti-counterfeiting and product security technology providers, where he gained an in- depth, global perspective on counterfeit pharmaceuticals and medical devices. He is a writer, seminar leader, and international conference speaker on pharmaceutical security matters. His article “Drugs for the Developing World: Obligation, Opportunity and Threat” won the Royal Society of Medicine Oswald Morton Essay Prize in 2010.
Wow! eBook


